Thus, a serum AFP concentration of 400 μg/L was applied as a boundary point in the current study and revealed that patients with a lower AFP concentration and CK-19+ tumor tissues were more likely to experience a poor prognosis, including both early recurrence and distant metastasis. This evidence concerns the gene KRT19 and neoplasm.